About Notal Vision Inc
Notal Vision is a pioneering digital health company that extends eye disease management from the clinic to the home, addressing unmet diagnostic needs in ophthalmology through precision medicine. The company has developed a proven approach combining home-based, patient-operated diagnostics with artificial intelligence-enabled data analysis to advance eye care outcomes. Their flagship product, ForeseeHome, helps doctors diagnose wet AMD earlier, validated through the AREDS2 HOME Study involving 1,520 patients that demonstrated significant vision benefits. The company also offers SCANLY Home OCT, which provides actionable insights between office visits for wet AMD care. Notal Vision operates a comprehensive Monitoring Center, a Medicare-recognized Independent Diagnostic Testing Facility (IDTF) directed by practicing ophthalmologists and supported by certified ophthalmic professionals. This center serves as the epicenter for patient and physician engagement, providing 24/7 connectivity, real-time automated analysis of patient testing data, and comprehensive support services. Founded in Tel Aviv and now headquartered in Manassas, Virginia, Notal Vision combines innovative Israeli R&D with veteran industry leadership. The company's approach enables treatment decisions based on each patient's disease activity rather than pre-scheduled clinic appointments, bringing precision medicine to eye care through novel diagnostic data and AI-driven analysis.
Mission & Story
Mission
Connecting patients and physicians beyond the clinic to advance eye care by bringing standard of care diagnostics into the home and using proprietary AI algorithms to deliver better outcomes
Founding Story
Notal Vision has its roots in the innovative culture of Tel Aviv, a globally recognized center of hardware and software distribution. The pioneering research and development team at Notal Vision sought to change the lives of people with Age-related Macular Degeneration (AMD) with a simple, daily, at-home test, resulting in ForeseeHome. Following the highly significant results from the AREDS2 HOME Study demonstrating vision benefits, Notal Vision launched the product and gained US Medicare reimbursement in late 2015.
Clinical Focus
Medical conditions and clinical areas addressed by Notal Vision Inc.
Who It Serves
Milestones & Awards
Recent Milestones
FDA de novo marketing authorization for SCANLY Home OCT breakthrough designation device (2024), AI-powered daily home OCT analysis capabilities (2025)
Key Partnerships
Company Details
- Headquarters
- Manassas, VA, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.